This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Church & Dwight (CHD) Q3 Earnings Beat Mark, Sales Rise Y/Y
by Zacks Equity Research
Church & Dwight's (CHD) third-quarter 2022 results reflect increased sales on growth in Consumer Domestic and Specialty Products units. However, earnings decline year over year.
Why Is Medifast (MED) Down 19.8% Since Last Earnings Report?
by Zacks Equity Research
Medifast (MED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Medifast (MED) Down More Than 20% in 3 Months on Cost Woes
by Zacks Equity Research
Medifast (MED) has been seeing high SG&A expenses and escalated raw material costs. The company expects short-term margin pressure in 2022 due to inflation and continued investments.
Are Options Traders Betting on a Big Move in Medifast (MED) Stock?
by Zacks Equity Research
Investors need to pay close attention to Medifast (MED) stock based on the movements in the options market lately.
Medifast (MED) Q2 Earnings Top Estimates, Guidance Lowered
by Zacks Equity Research
Medifast's (MED) second-quarter 2022 results reflect increased active earning OPTAVIA Coaches and elevated costs. Management cuts guidance for 2022 due to inflation.
Medifast (MED) Surpasses Q2 Earnings Estimates
by Zacks Equity Research
Medifast (MED) delivered earnings and revenue surprises of 17.99% and 2%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks.com featured highlights include UFP Industries, MEDIFAST, Skyline, Hudson Global and Expeditors International of Washington
by Zacks Equity Research
UFP Industries, MEDIFAST, Skyline, Hudson Global and Expeditors International of Washington are part of Zacks Screen of the Week article.
Medifast (MED) Readies for Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Medifast's (MED) second-quarter 2022 results are likely to reflect gains from its OPTAVIA lifestyle solution and coaching support system, while escalated costs might have been a concern.
Explore DuPont Analysis & Pick 5 Top Stocks
by Sanghamitra Saha
Do you have more faith in DuPont analysis than simple ROE calculation? Tap UFP Industries (UFPI), MEDIFAST (MED), Skyline (SKY), Hudson Global (HSON) and Expeditors International of Washington (EXPD).
Dive Into DuPont Analysis & Pick 5 Top Stocks
by Sanghamitra Saha
Do you have more faith in DuPont analysis than simple ROE calculation? Tap Sanderson Farms (SAFM), MEDIFAST (MED), Skyline (SKY), Hudson Global (HSON) and Expeditors International of Washington (EXPD).
Pilgrim's Pride (PPC) Q2 Earnings Beat, Sales Improve Y/Y
by Zacks Equity Research
Pilgrim's Pride's (PPC) second-quarter 2022 results reflect increased earnings and sales on growth across Mexico and Europe and the U.S. operations.
Hershey (HSY) Beats on Q2 Earnings & Sales, Raises 2022 View
by Zacks Equity Research
Hershey's (HSY) second-quarter 2022 results reflect higher earnings and sales on growth across all segments. Management raises 2022 guidance.
Medifast (MED) is a Top Dividend Stock Right Now: Should You Buy?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Medifast (MED) have what it takes? Let's find out.
Are Investors Undervaluing Greencore Group (GNCGY) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Kraft Heinz (KHC) Q2 Earnings Top Estimates, Sales Fall Y/Y
by Zacks Equity Research
The Kraft Heinz Company's (KHC) second-quarter 2022 results reflect lower earnings and sales. Nevertheless, management raises the 2022 organic net sales view.
Kimberly-Clark (KMB) Q2 Earnings Miss Mark, Sales Rise Y/Y
by Zacks Equity Research
Kimberly-Clark's (KMB) second-quarter 2022 earnings decline year over year. Nevertheless, sales increase on growth across all segments.
Inter Parfums (IPAR) Ups 2022 Guidance on Robust Q2 Sales
by Zacks Equity Research
Inter Parfums' (IPAR) sales increase year over year in second-quarter 2022. Management raises its top-and bottom-line view for 2022.
Campbell Soup (CPB) Looks Delectable on Solid Brands & Savings
by Zacks Equity Research
Campbell Soup's (CPB) prudent investment and strategic efforts in product innovation and brand building bode well. Also, it is progressing well with cost-saving plans.
Inter Parfums (IPAR) Partners With G-III Apparel to Fuel Growth
by Zacks Equity Research
Inter Parfums (IPAR) finalizes an agreement with G-III Apparel to become the exclusive worldwide licensee for the Donna Karan and DKNY fragrance brands.
Zacks.com featured highlights Sanderson Farms, MEDIFAST, Skyline, Hudson Global and Expeditors International of Washington
by Zacks Equity Research
Sanderson Farms, MEDIFAST, Skyline, Hudson Global and Expeditors International of Washington have been highlighted in this Screen of the Week article.
The J.M. Smucker (SJM) Rewards Investors With Dividend Hike
by Zacks Equity Research
The J.M. Smucker (SJM) rewards shareholders by raising the quarterly dividend. The company is progressing with core priorities.
Dive Into DuPont Analysis & Pick 5 Top Stocks
by Sanghamitra Saha
Do you have more faith in DuPont analysis than simple ROE calculation? Tap Sanderson Farms (SAFM), MEDIFAST (MED), Skyline (SKY), Hudson Global (HSON) and Expeditors International of Washington (EXPD).
Chefs' Warehouse (CHEF) Soars 5.4%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Chefs' Warehouse (CHEF) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Lamb Weston (LW) Stock Up More Than 15% YTD: Here's Why
by Zacks Equity Research
Lamb Weston (LW) benefits from a recovery in the Foodservice business. The company's efforts to boost production capacity and fuel long-term growth are yielding.
Solid Skin Care Business Aids The Estee Lauder Companies (EL)
by Zacks Equity Research
The Estee Lauder Companies (EL) is benefiting from strong e-commerce business. Also, the company's Skin Care portfolio has been performing well.